Cart
sales@molnova.com
Home - Products - Cell Cycle/DNA Damage - DNA/RNA Synthesis - Sempervirine

Sempervirine

CAS No. 6882-99-1

Sempervirine( —— )

Catalog No. M24702 CAS No. 6882-99-1

Sempervirine can unwind circular DNA, it shows selective inhibition of in vitro synthesis of cancer DNA .

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 468 In Stock
10MG 678 In Stock
25MG 1044 In Stock
50MG 1413 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Group Booking Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Sempervirine
  • Note
    Research use only, not for human use.
  • Brief Description
    Sempervirine can unwind circular DNA, it shows selective inhibition of in vitro synthesis of cancer DNA .
  • Description
    Sempervirine can unwind circular DNA, it shows selective inhibition of in vitro synthesis of cancer DNA .
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    DNA/RNA Synthesis
  • Recptor
    DNA/RNA Synthesis
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    6882-99-1
  • Formula Weight
    272.4
  • Molecular Formula
    C19H16N2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    [N+]12=CC3=C(CCCC3)C=C1C(NC4=CC=CC=C45)=C5C=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Selective inhibition of in vitro synthesis of cancer DNA by alkaloids of beta-carboline class.Exp Cell Biol. 1982;50(2):79-87.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • T2AA

    T2AA is an inhibitor of proliferating cell nuclear antigen (PCNA) with IC50 of 1 μM for PCNA/PIP-box peptide interaction.

  • 6-Mercaptopurine mon...

    ercaptopurine is a widely used antileukemic agent and immunosuppressive drug that inhibits de novo purine synthesis through incorporation of thiopurine methyltransferase metabolites into DNA and RNA.

  • L82-G17

    L82-G17 is an uncompetitive LigI-selective inhibitor in human cells with utility as a probe of the catalytic activity and cellular functions of LigI.

Sign In Join Free